The Role of Complement in B Cell Activation and Tolerance

Advances in Immunology

Volumn , Issue 74, 2000, Pages 61-88

  Carroll, Michael C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3;

B LYMPHOCYTE; COMPLEMENT ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033990632     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (93)

1. Agnello, V. (1978). Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum. 21, 146.
2. Ahearn, J., Fischer, M., Croix, D., Goerg, S., Ma, M.,Xia, J., Zhou,X., Howard, R., Rothstein, T., and Carroll, M. (1996). Disruption of the Cr2 locus results in a reduction in B-la cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
3. Ahearn, J. M., and Fearon, D. T. (1989). Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46, 183-219.
4. Bitter-Suermann, D., and Burger, R. (1989). C3 deficiencies. Curr. Topics Microbiol. Immunol. 153, 223-233.
5. Does, M., Prodeus, A., Schmidt, T., Carroll, M. C., and Chen, J. (1998). A critical role of natural IgM in immediate response against systemic bacterial infection. J. Exp. Med. 188, 2381-2386.
6. Bordet, J., and Gengou, O. (1901). Sur l'existence de substances sensibilisatrices dans la plupart des serum antimicrobiens. Annal Inst. Pasteur 15, 289-302.
7. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandollfi, P. P., and Walport, M. (1998). Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56-59.
8. Bumet, F. M. (1959). "The Clonal Selection Theory of Acquired Immunity." Vanderbilt University Press, Nashville, TN.
9. Carroll, M. C. (1998). The lupus paradox. Nature Genet. 19, 3-4.
10. Carroll, M. C., Alicot, E. M., Katzman P. J., Klickstein, L. B., Smith, J. A., and Fearon, D. T. (1988). Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.J. Exp. Med. 167, 1271.
11. Carroll, M. C., Campbell, R. D., Bentley, R. D., and Porter, R. R. (1984). A molecular map of the major histocompatibility complex class III region of man linking the complement genes C4, C2, and factor B. Nature 307, 237-241.
12. Carsetti, R., Kohler, G., and Lamers, M. C. (1995). Transitional B cells are the target of negative selection in the B cell compartment.J. Exp. Med. 181, 2129-2140.
13. Carter, R. H., and Fearon, D. T. (1992). CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107.
14. Casciola-Rosen, L. A., Anhalt, G., and Rosen, A. (1994). Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330.
15. Chen, C., Nagy, Z., Radie, M. Z., Hardy, R. R., Huszar, D., Camper, S. A., and Weigert, M. (1995). The site and stage of anti-DNA B-cell deletion. Nature 373, 252-255.
16. Cotran, R. S., Kumar, V., and Robbins, S. L. (1994). "Pathologie Basis of Disease." W. B. Saunders, Philadelphia.
17. Croix, D., Ahearn, J., Rosengard, A., Han, S., Kelsoe, G., Ma, M., and Carroll, M. (1996). Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183, 1857-1864.
18. Cutler, A., Botto, M., van Essen, D., Rivi, R., Davies, K., Gray, D., and Walport, M. (1998). T cell-dependent immune response in Clq-deficient mice: Defective interferon gamma production by antigen-specific T cells.J. Exp. Med. 187, 1789-1797.
19. Cyster, J. G., and Goodnow, C. C. (1995). Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines the thresholds for negative selection. Immunity 2, 13-24.
20. Cyster, J. G., Healy, J. L, Kishihara, K., Mak, T. W., Thomas, M. L., and Goodnow, C. C. (1996). Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381, 325-328.
21. Dempsey, P., Allicson, M., Akkaraju, S., Goodnow, "c., and Fearon, D. (1996). C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271, 348-350.
22. Engel, P., Zhou, L. J., Ord, D. C., Sata, S., Koller, B., and Tedder, T. F. (1995). Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress die CD19 signal transduction molecule. Immunity 3, 39-50.
23. Epstein, J., Eichbaum, Q. E., Sheriff, S., and Ezekowitz, R. A. B. (1996). The collectas in innate immunity. Curr. Opin. Immunol. 8, 29-35.
24. Fang, Y., Xu, C., Fu, Y., Holers, V. M., and Molina, H. (1998). Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160, 5273-5279.
25. Fearon, D. T., and Carter, R. H. (1995). The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Arm. Rev. Immunol. 13, 127-149.
26. Fearon, D. T., and Locksley, R. M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272, 50-54.
27. Fearon, D. T., and Wong, W. W. (1983). Complement ligand-receptor interactions that mediate biological responses. Anna. Rev. Immnnol. 1, 243-260.
28. Finco, O., Li, S., Cuccia, M-C., Rosen, F. S., and Carroll, M. C. (1992). Structural differences between the two human complement C4 isotypes affects the humoral immune response. J. Exp. Med. 175, 537-543.
29. Fischer, M., Ma, M., Goerg, S., Zhou, X., Xia, J., Finco, O., Han, S., Kelsoe, G., Howard, R., Rothstein, T., Kremmer, E., Rosen, F. S., and Carroll, M. C. (1996). Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549-556.
30. Fischer, M. B., Goerg, S., Shen, L. M., Prodeus, A. P., Goodnow, C. C., Kelsoe, G., and Carroll, M. C. (1998a). Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582-585.
31. Fischer, M. B., Ma, M., Hsu, N., and Carroll, M. C., (1998b). Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J. Immunol. 160, 2619-1625.
32. Garrone, P., Neidardt, E. M., Garcia, E., Gailbert, L., van Kooten, C., and Banchereau, J. (1995). fas ligation induces apoptosis of Cd40-activated human B lymphocytes. J. Exp. Med. 182, 1265-1273.
33. Goodnow, C., Cyster, J., Hartley, S., Bell, S., Cooke, M., Healy, J., Akkaraju, S., Rathmell, J., Pogue, S., and Shokat, K. (1995). Self-tolerance checkpoints in B lymphocyte development. Adv. Immnnol. 59, 279-369.
34. Goodnow, C.C. (1996). Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93, 2264-2271.
35. Goodnow, C. C., Crosbie, J., Jorgensen, H., Brink, R. A., and Basten, A. (1989). Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342, 385-391.
36. Han, S., Zheng, B., Dal Porto, J., Kelsoe, G. (1995). In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining!! self-tolerance. J. Exp. Med. 182, 1635-1644.
37. Harrison, R. A., Thomas, M. L., and Tack, B. F. (1981). Sequence determination of the thiolester site of the fourth component of human complement. Proc. Natl. Acad. Sci. USA 78, 7388-7392.
38. Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A., and Goodnow, C.C. (1991). Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353, 765-769.
39. Hartley, S. B., and Goodnow, C. C. (1994). Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. Int. Immunol. 6, 1417-1425.
40. Heyman, B., Pilstrom, L., and Shulman, M. (1988). Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 167, 1999-2004.
41. Inaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C., and Tedder, T. F. (1997). CD19 regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.J. Exp. Med. 186, 1923-1931.
42. Janeway, C. A. (1989). Approaching the asymtote? Evolution and revolution in immunology. Cold Spring Harbour Sym. Quant. Biol. 54, 1.
43. Kalli, K. R., and Fearon, D. T. (1994). Binding of C3b and C4b by the CRl-like site in murine CR1. J. Immunol. 152, 2899-2903.
44. Kantor, A. B., and Herzenberg, L. A. (1993). Origin of murine B cell lineages. Annu. Rev. Immunol 11, 501-538.
45. Kelsoe, G. (1995). The germinal center reaction. Immunol. Today 16, 324-326.
46. Kinoshita, T., Lavoie, S., and Nussenzweig, V. (1985). Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor l (CR1). J. Immunol. 134, 2564.
47. Kinoshita, T., Takeda, J., Hong, K., Kozono, H., Sakai, H., and Inoue, K. (1988). Monoclonal antibodies to mouse complement receptor type l (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CRl-negative. J. Immunol. 140,3066.
48. Klaus, G. G. B., Humphrey, J. H., Kunkl, A., and Dongworth, D. W. (1980). The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53, 3-59.
49. Korb, L. C., and Ahearn, J. M. (1997). Clq binds directly and specifically to surface blebs of apoptotic keratinocytes. J. Immunol. 158, 4525-4528.
50. Kurtz, C. B., OToole, E., Christensen, S. M., and Weis, J. H. (1990). The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CRI.J. Immunol. 144, 3581-3591.
51. Lavoie, T., Drohan, W., and Smith-Gill, S. (1992). Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J. Immunol. 148, 503-513.
52. Law, S. K., Lichtenberg, N. A., and Levine, R. P. (19SO). Covalent binding and hemolytic activity of complement proteins. Proc. Natl. Acad. Sei. USA 77, 7194-7198.
53. MacLennan, I. (1994). Germinal Centers. Ann. Rev. Immtinol. 12, 117-139.
54. Mandik-Nayak, L., Bui, A., Noorchashm, II., Eaton, A., and Erikson, J. (1997). Regulation of anti-double stranded DNA B cells in nonautoimmune mice: Localization to the T-B interface of the splenic follicle.J. Exp. Med. 186, 1257-1267.
55. Matzinger, P. (1994). Tolerance, danger, and the extended family. Anmi. Rev. Immunol. 12, 991-1045.
56. Michel, C. J., McKenna, C. H., Elveback, L. R., Kaslow, R. A., and Jurland, L. T. (1979). Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 60, 105-113.
57. Miyakawa, Y., Yamada, A., Kosaka, K., Tsuda, F., Kosugi, E., and Mayumi, M. (1981). Defective immune adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 11, 493-497.
58. Molina, H., Holers, V., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R., and Chaplin, D. (1996). Markedkly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sei. USA 93,3357-3361.
59. Molina, H., Kinoshita, T., Inoue, K., Carel, J-C., and Holers, V. M. (1990). A molecular and immunochemical characterization of mouse CR2. J. Immunol. 145, 2974-2983.
60. Molina, IL, Kinoshita, T., Webster, C. B., and Holers, V. M. (1994). Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immtinol. 153, 789-795.
61. Muller-Eberhard, H. J. (1988). Molecular organization and function of the complement system. Ann. Rev. Biochcm. 57, 321-347.
62. Nemazee, D., and Buerki, K. (19S9). Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sei. USA 86, 8039-8043.
63. Norvell, A., Mandik, L., and Monroe, J. G. (1995). Engagement of the antigen receptor on immature murine B lymphocytes results in death by apoptosis.J. Immunol. 154,4404-4413.
64. Norvell, A., and Monroe, J. G. (1996). Acquisition of surface IgD fails to protect from tolerance-induction: Both surface IgM-and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes. J. Immunol. 156, 1328-1332.
65. Nossal, G. J. V. (19S3). Cellular mechanisms of immunologie tolerance. Ann. Rev. Immunol. 1, 33-62.
66. Nussenzweig, V., Bianco, C., Dukor, P., and Eden, A. (1971). "Receptors for C3 on B Lymphocytes: Possible Role in the Immune Response." Academic Press, New York.
67. O'Rourke, L., Tooze, R., Turner, M., Sandoval, D., Carter, R., Tybulewicz, V., and Fearon, D. (1998). CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8, 635-645.
68. Ochs, H. D., Wedgewood, R. J., Heller, S. R., and Beatty, P. G. (1986).Complement, membrane glycoproteins and complement receptors. Their role in regulation of the immune response. Clin. Immunol. Immunopathol. 40, 94-104.
69. Papamichail, M., Gutierrez, C., Embling, P., Johnson, P., Holborow, E. J., and Pepys, M. B. (1975). Complement dependence of localization of aggregated IgG in germinal centers. Scand. ]. Immunol. 4, 343.
70. Pepys, M. B. (1972). Role of complement in induction of the allergic response. Nature: New Biol. 237, 157-159.
71. Pisetsky, D. S., Grudier, J. P., and Gilkeson, G. S. (1990). A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Art/irif is 6- Rheumatism 33,154-159.
72. Prodeus, A. P., Goerg, S., Shen, L. M., Pozdnykova, O. O., Chu, L., Alicot, E., Goodnow, C. C., and Carroll, M. C. (1998). A critical role for complement in maintenance of self-tolerance. Immunity 9, 721-731.
73. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. C., and Nossal, G. J. V. (1995). Soluble antigen can cause enhanced apoptosis of germinal center D cells. Nature 375, 331-333.
74. Qin, D., Wu, J., Carroll, M. C., Burton, G. F., Szakal, A. K., and Tew, J. G. (1998). Antibody production and B cell-FDC communication via CD21-CD21 ligand. J. Immunol. 161, 4549-4554.
75. Rathmell, J. C., Cooke, M. P., Ho, W. Y., Grein, J., Townsend, S. E., Davis, M. M., and Goodnow, C. C. (1995). CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376, 181-184.
76. Reid, K. B. M., and Porter, R. R. (1981). The proteolytic activation systems of complement. Atmu. Rev. Biochem. 50, 433-464.
77. Rickert, R. C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent B cell responses and B-l cell development in CD19-deficient mice. Nature 376, 352-355.
78. Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Gui, IL, Ju, S-T., and Marshak-Rothstein, A. (1995). Protection against Thl-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
79. Santulli-iMarotto, S., Retter, M. W., Gee, R.; Mamula, M. J., and Clarke, S. H. (1998). Autoreactive B cell Regulation: Peripheral induction of developmental arrest by lupusassociated autoantigens. Immunity 8, 209-219.
80. Sato, S., Jansen, P., and Tedder, T. (1997). CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc. Natl. Acad. Sci. USA 94, 13158-62.
81. Schifferli, J. A., Ng, Y. C., and Peters, D. K. (1976). The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 315, 488-495.
82. Shokat, K., and Goodnow, C. (1995). Antigen-induced B-cell death and elimination during germinal centre immune response. Nature 375, 334-338.
83. Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L., and Prahl, J. W. (1980). Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl Acad. Sei. USA 77, 5764-5768.
84. Takahashi, K., Kozono, Y., Waldschmidt, T. J., Berthiaume, D., Quigg, R. J., Baron, A., and Holers, V. M. (1997). Mouse complement receptors type 1 (CR1;CD35) and type 2 (Cr2;CD21) expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.J. Immunol. 159, 1557-1569.
85. Takahashi, T., Tanaka, M., Brannan, C. L, Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
86. Takai, T., Ono, M., Hikida, M., Ohmori, H., and Ravetch, J. (1996). Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379, 346-349.
87. Tan, E. M. (1982). Autoantibodies to nuclear antigens: their immunobiology and medicine. Adv. Immunol. 33, 167-240.
88. Tedder, T. F., Zhou, L. J., and Engel, P. (1994). The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15, 437-441.
89. Theofilopoulos, A. N., and Dixon, F. J. (1985). Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269.
90. Thomton, B. P., Vetvicka, V., and Ross, G. D. (1994). Natural antibody and complementmediated antigen processing and presentation by B lymphocytes.J. Immunol. 152,1727-1737.
91. Vora, K. A., Ravetch, J. V., and Manser, T. (1997). Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response. J. Immtmol. 159, 2116-2124.
92. Walport, M. J., and Morgan, B. P. (1991). Complement deficiency and disease. Immunol. Today 12, 301-306.
93. Wu, J., Qin, D., Burton, G. F., Szakal, A. K., and Tew, J. G. (1996). Follicular dendritic cell (FDC) derived Ag and accessory activity in initiation of memory IgG responses in vitro. J. Immunol. 157, 3404.